Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-02

Clinical Trial Update: Testosterone MD-Lotion Residual Washing Study [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Testosterone MD-Lotion for hypergonadism, including residual washing assessment, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Testosterone MD-Lotion (testosterone)

Snippet

Sponsor: Acrux DDS Pty Ltd | Conditions: Hypergonadism | Phase 1 | Status: COMPLETED